Malegra DXT is marketed as a combination medicine containing sildenafil and duloxetine. Sildenafil is a PDE5 inhibitor used to treat erectile dysfunction (ED), while duloxetine is an antidepressant that may affect ejaculation and is sometimes included in products marketed for sexual-performance concerns.

Sildenafil may improve erection firmness by increasing blood flow to the penis when a man is sexually stimulated. A firmer erection can make penetration easier to achieve and maintain. However, sildenafil does not directly increase penile size or physically strengthen the penis. It also does not increase sexual desire and requires sexual stimulation to work.

Duloxetine affects serotonin and norepinephrine signaling in the nervous system. Medicines in this class can influence ejaculation, although duloxetine is not specifically approved for premature ejaculation. Its use for this purpose should therefore be discussed with a qualified healthcare professional.

Malegra DXT should not be taken without appropriate medical advice. Sildenafil can interact dangerously with nitrate medicines, potentially causing a significant drop in blood pressure. Duloxetine also has important interactions, including with certain antidepressants and medicines affecting serotonin.

Possible side effects may include headache, flushing, indigestion, dizziness, nausea, dry mouth, and changes in blood pressure. Individual responses vary, and combining prescription medicines without professional guidance can be risky.

Overall, the sildenafil component may support a firmer erection and therefore facilitate penetration when erectile dysfunction is present. However, Malegra DXT should be used only under medical supervision, particularly because it combines two active medicines with potentially significant interactions.